TCL Archive The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data September 25, 1998
TCL Archive Defying critics, von Eschenbach describes hands-on role at NCI while running FDA. NCI is unified behind 2015 goal, he says. December 9, 2005
TCL Archive FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe December 5, 1986
